Investor Presentaiton
о
For personal use only
Statutory Reconciliation to Underlying FY20
Impact of significant items on Statutory results
Underlying
Exceptional
Deferred
$m
Total Revenue
Gross Profit
FY20 transactions
revenue
Contract
adjustment
Statutory
FY20
128.4
(0.6)
(5.7)
122.1
55.8
(0.6)
(4.3)
50.9
Gross Profit Margin
43.5%
41.7%
EBITDA
29.2
(7.5)
(0.6)
(4.3)
16.8
EBITDA Margin
22.7%
19.9%
Depreciation & Amortisation
12.2
12.2
EBIT
17.0
(7.5)
(0.6)
(4.3)
4.6
Finance Costs
NPBT
Tax Expense
NPAT from Continuing Operations
2.1
2.1
14.9
(7.5)
(0.6)
(4.3)
2.5
3.3
(0.4)
(0.1)
(1.3)
1.5
11.6
(7.1)
(0.5)
(3.0)
1.0
Net loss from discontinued operations
(0.1)
(0.1)
Net profit for the year
11.5
(7.1)
(0.5)
(3.0)
0.9
Other comprehensive loss
(15.8)
(15.8)
Total comprehensive income/(loss)
(4.3)
(7.1)
(0.5)
(3.0)
(14.9)
Citadel Group | Investor Presentation | 28
Exceptional transactions $7.5 million
> Wellbeing non-capitalised acquisition and integration
costs $6.7m
> Group restructuring costs $0.7m
Deferred revenue $0.6 million
> Wellbeing deferred revenue acquired fair value
adjustment
Contract adjustment $5.7 million
> A $5.7 million reversal of a contract asset (income
accrual) under AASB 15 that was originally recognised
in FY17 and FY18 (of which up to $5 million is expected
to be recovered in FY21), and the reversal of an over
accrual in respect of a sub-contract of $1.4 million in
respect of the same project. The change in accounting
treatment arises as a result of the contract no longer
being expected to be fully completed and the final
payment yet to be agreed.View entire presentation